UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 547

Sortiert nach

PDE5 inhibition improves cardiac morphology and function in SHR by reducing NHE1 activity: Repurposing Sildenafil for the treatment of hypertensive cardiac hypertrophy

European journal of pharmacology, 2021-01, Vol.891, p.173724-173724, Article 173724

2021

Volltextzugriff (PDF)

p38 mitogen activated protein kinase mediates cardiac Na+/H+ exchanger inhibition induced by Sildenafil

European journal of pharmacology, 2019-04, Vol.849, p.96-105

2019

Volltextzugriff (PDF)

Silencing of epidermal growth factor receptor reduces Na+/H+ exchanger 1 activity and hypertensive cardiac hypertrophy

Biochemical pharmacology, 2019-12, Vol.170, p.113667-113667, Article 113667

2019

Volltextzugriff (PDF)

Epidermal Growth Factor Receptor Silencing Blunts the Slow Force Response to Myocardial Stretch

Journal of the American Heart Association, 2016-10, Vol.5 (10), p.n/a

2016

Volltextzugriff (PDF)

A bacteraemia risk prediction model: development and validation in an emergency medicine population

Infection, 2022-02, Vol.50 (1), p.203-221

2022

Volltextzugriff (PDF)

A Positive Allosteric Modulator of the Serotonin 5‑HT2C Receptor for Obesity

Journal of medicinal chemistry, 2017-12, Vol.60 (23), p.9575-9584

2017

Volltextzugriff (PDF)

Serum exosome inflamma‐miRs are surrogate biomarkers for asthma phenotype and severity

Allergy (Copenhagen), 2023-01, Vol.78 (1), p.141-155

2023

Volltextzugriff (PDF)

2‑(Fluoromethoxy)-4′‑(S‑methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D1 Receptor for Parkinson’s Disease

Journal of medicinal chemistry, 2022-09, Vol.65 (18), p.12256-12272

2022

Volltextzugriff (PDF)

Enantiospecific Recognition at the A2B Adenosine Receptor by Alkyl 2‑Cyanoimino-4-substituted-6-methyl-1,2,3,4-tetrahydropyrimidine-5-carboxylates

Journal of medicinal chemistry, 2017-04, Vol.60 (8), p.3372-3382

2017

Volltextzugriff (PDF)

Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR‑6

Journal of medicinal chemistry, 2020-09, Vol.63 (17), p.9360-9390

2020

Volltextzugriff (PDF)

Cellular Models for Primary CoQ Deficiency Pathogenesis Study

International journal of molecular sciences, 2021-10, Vol.22 (19), p.10211

2021

Volltextzugriff (PDF)

Cognitive Deficit in Schizophrenia: From Etiology to Novel Treatments

International journal of molecular sciences, 2021-09, Vol.22 (18), p.9905

2021

Volltextzugriff (PDF)

Discovery of V‑0219: A Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide‑1 Receptor toward Oral Treatment for “Diabesity”

Journal of medicinal chemistry, 2022-04, Vol.65 (7), p.5449-5461

2022

Volltextzugriff (PDF)

Reflect, Reframe, and Re-Imagine Theory and Practice in Speech, Language, and Hearing Sciences: Introduction to the Forum

Language, speech & hearing services in schools, 2023-07, Vol.54 (3), p.671

2023

Volltextzugriff (PDF)

Assessing tourist behavioral intentions through perceived service quality and customer satisfaction

Journal of business research, 2007-02, Vol.60 (2), p.153-160

2007

Volltextzugriff (PDF)

Comparison between MOF UTSA-16 and BPL activated carbon in hydrogen purification by PSA

Chemical engineering journal (Lausanne, Switzerland : 1996), 2019-01, Vol.355, p.279-289

2019

Volltextzugriff (PDF)

Effect of Nitrogen Atom Substitution in A3 Adenosine Receptor Binding: N‑(4,6-Diarylpyridin-2-yl)acetamides as Potent and Selective Antagonists

Journal of medicinal chemistry, 2017-09, Vol.60 (17), p.7502-7511

2017

Volltextzugriff (PDF)

5-HT2 receptor binding, functional activity and selectivity in N-benzyltryptamines

PloS one, 2019-01, Vol.14 (1), p.e0209804-e0209804

2019

Volltextzugriff (PDF)

2‑Oxaadamant-1-yl Ureas as Soluble Epoxide Hydrolase Inhibitors: In Vivo Evaluation in a Murine Model of Acute Pancreatitis

Journal of medicinal chemistry, 2020-09, Vol.63 (17), p.9237-9257

2020

Volltextzugriff (PDF)

Risk of Cancer in Cases of Suspected Lynch Syndrome Without Germline Mutation

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.926-932.e1

2013

Volltextzugriff (PDF)

Trifluorinated Pyrimidine-Based A2B Antagonists: Optimization and Evidence of Stereospecific Recognition

Journal of medicinal chemistry, 2019-10, Vol.62 (20), p.9315-9330

2019

Volltextzugriff (PDF)

A novel mechanism of neuroprotection: Blood glutamate grabber

Journal of Cerebral Blood Flow & Metabolism, 2016-02, Vol.36 (2), p.292-301

2016

Volltextzugriff (PDF)

Exploring the Effect of Halogenation in a Series of Potent and Selective A2B Adenosine Receptor Antagonists

Journal of medicinal chemistry, 2023-01, Vol.66 (1), p.890-912

2023

Volltextzugriff (PDF)

Novel Phthalazin-1(2H)-One Derivatives Displaying a Dithiocarbamate Moiety as Potential Anticancer Agents

Molecules (Basel, Switzerland), 2022-11, Vol.27 (23), p.8115

2022

Volltextzugriff (PDF)

1 – 25 von 547

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(487)
Mit Volltextzugriff
(511)

Publikationsform

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

PDE5 inhibition improves cardiac morphology and function in SHR by reducing NHE1 activity: Repurposing Sildenafil for the treatment of hypertensive cardiac hypertrophy

p38 mitogen activated protein kinase mediates cardiac Na+/H+ exchanger inhibition induced by Sildenafil

Silencing of epidermal growth factor receptor reduces Na+/H+ exchanger 1 activity and hypertensive cardiac hypertrophy

Epidermal Growth Factor Receptor Silencing Blunts the Slow Force Response to Myocardial Stretch

A bacteraemia risk prediction model: development and validation in an emergency medicine population

A Positive Allosteric Modulator of the Serotonin 5‑HT2C Receptor for Obesity

Serum exosome inflamma‐miRs are surrogate biomarkers for asthma phenotype and severity

2‑(Fluoromethoxy)-4′‑(S‑methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D1 Receptor for Parkinson’s Disease

Enantiospecific Recognition at the A2B Adenosine Receptor by Alkyl 2‑Cyanoimino-4-substituted-6-methyl-1,2,3,4-tetrahydropyrimidine-5-carboxylates

Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR‑6

Cellular Models for Primary CoQ Deficiency Pathogenesis Study

Cognitive Deficit in Schizophrenia: From Etiology to Novel Treatments

Discovery of V‑0219: A Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide‑1 Receptor toward Oral Treatment for “Diabesity”

Reflect, Reframe, and Re-Imagine Theory and Practice in Speech, Language, and Hearing Sciences: Introduction to the Forum

Assessing tourist behavioral intentions through perceived service quality and customer satisfaction

Comparison between MOF UTSA-16 and BPL activated carbon in hydrogen purification by PSA

Effect of Nitrogen Atom Substitution in A3 Adenosine Receptor Binding: N‑(4,6-Diarylpyridin-2-yl)acetamides as Potent and Selective Antagonists

5-HT2 receptor binding, functional activity and selectivity in N-benzyltryptamines

2‑Oxaadamant-1-yl Ureas as Soluble Epoxide Hydrolase Inhibitors: In Vivo Evaluation in a Murine Model of Acute Pancreatitis

Risk of Cancer in Cases of Suspected Lynch Syndrome Without Germline Mutation

Beneficial effects of hepatic cyclooxygenase‐2 expression against cholestatic injury after common bile duct ligation in mice

Trifluorinated Pyrimidine-Based A2B Antagonists: Optimization and Evidence of Stereospecific Recognition

A novel mechanism of neuroprotection: Blood glutamate grabber

Exploring the Effect of Halogenation in a Series of Potent and Selective A2B Adenosine Receptor Antagonists

Novel Phthalazin-1(2H)-One Derivatives Displaying a Dithiocarbamate Moiety as Potential Anticancer Agents

Suchergebnisse filtern